Apple has released the results of its study aimed at determining the effectiveness of its smartwatch’s ability to alert wearers of irregular heartbeats that could point to atrial fibrillation, according to a FierceBiotech report.
The 8-month Apple Heart Study, which was launched in November last year in partnership with Stanford Medicine, involved 400,000 smartwatch users across the U.S.
According to the report, the study found 0.5 percent (about 2,000) of the study’s participants were alerted to an irregular heartbeat. Some 34 percent were confirmed to have atrial fibrillation; 57 percent sought medical help.
“The study’s findings have the potential to help patients and clinicians understand how devices like the Apple Watch can play a role in detecting conditions such as atrial fibrillation, a deadly and often undiagnosed disease,” Stanford University’s Mintu Turakhia said.
To read the full report on FierceBiotech, click here.